47
Views
5
CrossRef citations to date
0
Altmetric
Review

Integrins as targets in therapy

Pages 963-975 | Published online: 21 Jun 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jefferson W Tilley. (2008) Very late antigen-4 integrin antagonists. Expert Opinion on Therapeutic Patents 18:8, pages 841-859.
Read now

Articles from other publishers (4)

Achyutharao Sidduri, Jefferson W. Tilley, Jianping Lou, Nadine Tare, Gary Cavallo, Karl Frank, Anjula Pamidimukkala, Duk Soon Choi, Louise Gerber, Aruna Railkar & Louis Renzetti. (2013) Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4–beta1 and alpha4–beta7 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 23:4, pages 1026-1031.
Crossref
Jefferson W. Tilley, Achyutharao Sidduri, Jianping Lou, Gerry Kaplan, Nadine Tare, Gary Cavallo, Karl Frank, Anjula Pamidimukkala, Duk Soon Choi, Louise Gerber, Aruna Railkar & Louis Renzetti. (2013) Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 23:4, pages 1036-1040.
Crossref
Erin L. Baker & Muhammad H. Zaman. (2010) The biomechanical integrin. Journal of Biomechanics 43:1, pages 38-44.
Crossref
Pierre-Jean Wipff & Boris Hinz. (2008) Integrins and the activation of latent transforming growth factor β1 – An intimate relationship. European Journal of Cell Biology 87:8-9, pages 601-615.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.